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Volume 53, Number 17S Abstracts 65SConclusions: During the last two decades the natural
history of medically treated No Option CLI has improved.
Reduction in the AFS composite measure was predomi-
nantly influenced by mortality. A composite outcome
which includes survival may blur the limb specific benefits
of an intervention. The changing natural history data has
important implications for power calculations and endpoint
selection of future NOCLI trials.
Natural History of NOCLI
Outcome
(1 year)
Summary
Proportion
Coefficeint of\”final
Year Recruitment\”
p
Value
Amputation 0.35 (0.25, 0.46) 0.0252 (0.0621, 0.0117) 0.157
Death 0.18 (0.09, 0.31) 0.047 (0.9482, 0.0014) 0.056
AFS 0.55 (0.40, 0.69) 0.052 (0.001, 0.104) 0.047
Author Disclosures: E. Benoit: Nothing to disclose;
M. D. Iafrati: Nothing to disclose; G. Kitsios: Nothing to
disclose; T. F. O’Donnell: Nothing to disclose.
PS136.
Variation in the Use of Invasive Revascularization for
Severe Lower Extremity PAD in the Year Prior to
Amputation
Philip P. Goodney1, Nicholas H. Osborne3, Jack L.
Cronenwett1, Richard J. Powell1, F. Lee Lucas2, John D.
Birkmeyer3, Elliott S. Fisher1. 1Section of Vascular Sur-
gery, Dartmouth-Hitchcock Medical Center, Lebanon,
NH; 2Center for Outcomes Research and Evaluation, Port-
land, ME; 3University of Michigan, Ann Arbor, MI
Objectives: Many believe limited access to vascular
care represents a significant barrier in preventing lower
extremity amputation. Therefore, we sought to describe
the variation in vascular care obtained by patients with PAD
during the year prior to amputation.
Methods: Using Medicare claims (2003-2006), we
identified all patients with a diagnosis of PAD who under-
went major lower extremity amputation (n22,208) in
each of the 304 hospital referral regions (HRRs) described
in the Dartmouth Atlas of Healthcare. For each patient, we
studied the use of revascularization procedures (bypass
surgery or endovascular interventions) in the year prior to
amputation. Our main outcome measure was the intensity
of vascular care, defined as the proportion of patients in the
HRR who underwent any revascularization procedure in
the year prior to amputation.
Results: Overall, we studied 22,208 patients with
PAD who underwent 29,559 major lower extremity
amputations. In the year prior to amputation, vascular
intensity varied across regions. In the regions in the
lowest quintile of vascular intensity, lower extremity
revascularization was rarely attempted in the year prior
to amputation (1% of patients underwent bypass surgery,
1% endovascular interventions). Conversely, in the re-
gions in the highest quintile of vascular intensity, revas-
cularization was much more commonly performed in the uear prior to amputation (49% of patients underwent
ypass surgery, 48% endovascular interventions). Within
uintiles of vascular intensity, regions tended to use
ypass surgery and endovascular interventions similarly
Figure 1).
Conclusions: Dramatic disparities exist in the intensity
f vascular care provided to patients in the year prior to
mputation. In some regions, patients receive very intensive
are, while in other regions, far less vascular care is pro-
ided. Future work is needed to determine the association
etween intensity of vascular care and outcomes in the
reatment of patients with CLI.
uthor Disclosures: J. D. Birkmeyer: Nothing to dis-
lose; J. L. Cronenwett: Nothing to disclose; E. S. Fisher:
othing to disclose; P. P. Goodney: Nothing to disclose;
. Lucas: Nothing to disclose; N. H. Osborne: Nothing
o disclose; R. J. Powell: Nothing to disclose.
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id-Term Results of a Novel Regenerative Xenograft
ascular Patch
lan Dardik1, György Acsády2, Lajos Mátyás3, Istvan
ogán4, Paul van Eijkelenburg5. 1Department of Surgery,
ale University School of Medicine, New Haven, CT;
Semmelweis University Hospital, Budapest, Hungary;
Miskolc Hospital, Miskolc, Hungary; 4Szent Imre Hospi-
al, Budapest, Hungary; 5St. Elisabeth Hospitaal, Willem-
tad, Netherlands Antilles
Objectives: Prosthetic patches are commonly used to
lose arteriotomies such as performed after carotid or
emoral endarterectomy (FEA). Currently available syn-
hetic patches typically have poor compliance and are
rone to inflammatory infiltrates, contributing to long-
erm restenosis or pseudoaneurysm formation. We eval-
ariation in the Use of Invasive Lower Extremity Revasculariza-
ion, by Hospital Referral Region.ated the performance of a novel acellular, uncross-
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June Supplement 201166S Abstractslinked, porcine pericardial patch (dCELL, Tissue
Regenix, UK).
Methods: Informed consent was obtained. Elective
FEA with dCELL patch closure was performed using stan-
dard technique. Postoperative examination and Doppler
ultrasound was performed at 1, 3, 6, and 12 months.
Results: 21 patients participated; all were examined
at 6 months and 18 were followed at 12 months (86%).
64% were active smokers; 27% had diabetes; 55% had
previous vascular procedures. Mean time to hemostasis
was 3.5  2.1 min. Handling characteristics were con-
sidered excellent. There was one wound hemorrhage
requiring reoperation, not due to the patch. There was
one superficial wound infection not related to the patch.
There was one early asymptomatic occlusion (22 d)
associated with an occluded profunda. In mid-term fol-
lowup, 4 patients developed non-flow-limiting neointi-
mal hyperplasia 2mm; mean neointima was 0.78mm.
Mean mid-patch PSV was 93.3 cm/s at 12 months which
was similar to 90.18 cm/s at 1 month; there was no
change in mid-patch neointima at 1 and 6 months (di-
ameter 9.22 0.22 mm vs. 8.99 1.31 mm, p0.583).
No aneurysmal dilation occurred (mean internal diame-
ter 8.12 cm vs. 8.39 cm proximal, p0.71). In 56% it was
impossible to distinguish the patch wall due to remodel-
ling. There were no pseudoaneurysms.
Conclusions: dCELL porcine pericardial patches are
safe and effective for patch angioplasty, with minimal reste-
nosis and excellent tissue incorporation. dCELL patches
may be a platform for next-generation tissue-engineered
closure devices.
Author Disclosures: G. Acsády: Nothing to disclose; A.
Dardik: Nothing to disclose; I. Mogán: Nothing to dis-
close; L. Mátyás: Nothing to disclose; P. van Eijkelen-
burg: Nothing to disclose.
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Outcomes of Below-Knee Bypasses in African Origin
Patients for Critical Limb Ischemia: The French West
Indies Experience
Sherif Attia1, Michel Deneuville2. 1Pointe à Pitre Univer-
sity frensh center, Pointe à pitre cedex, Guadeloupe;
2Pointe à pitre university center, pointe à pitre cedex,
Guadeloupe
Objectives: Prior studies have documented racial and
ethnic disparities in rates of graft function and limb salvage
in the United States. We analyze the outcomes of below-
knee bypasses in the African origin (AO) patients in the
French West Indie.
Methods: This was a retrospective, comparative cohort
study of male and female of AO patients who had undergone
autogenous below-knee bypass surgery in a single center.
Results: One hundred seventeen below-knee by-
passes were performed for critical lower limb ischemia.
Compared with the male cohort, the female group were
significantly older (median age 77.4, 51-92 years, p.009) and presented with tissue loss CLI (84% VS75%
n male group, P.24).The great saphenous vein was
sed in both groups and limb salvage was the indication
f bypass. The 30day graft failure was significantly worse
n the female (24% VS12% in the male group, P.09).
he 2-year primary patency rate was also significantly
orse in the female patients 44% VS60% in the male
roup, P.01). The 2-year LS rate was significantly
orse 58% in the female group VS 73% in the male group
P0.012). With the Cox proportional hazard mode,
ignificant risk factors associated with primary graft fail-
re and LS as female sex, renal failure, tibial bypasses and
ein diameter.
Conclusions: In Guadeloupe, the AO race and female
ender are risk factors for adverse outcomes after vein bypass
urgery for limb salvage. Graft failure and limb loss are com-
on events in AO race, with women being a particular high
isk group.
uthor Disclosures: S. Attia: Nothing to disclose; M.
eneuville: Nothing to disclose.
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ate of Amputees following Below-Knee Amputation:
arly and Mid-Term Results
ulius Poon1, Sebastian Ko1, Musaad al-Ghamdi1, Heather
nderwood2, ElliottWeiss2, YorkN.Hsiang1. 1Vancouver
eneral Hospital, Vancouver, BC, Canada; 2GF Strong
nd Holy Family Hospitals, Vancouver, BC, Canada
Objectives: The objective of this study was to deter-
ine the outcomes of patients undergoing below-knee
mputation (BKA) for critical limb ischemia.
Methods: A retrospective review of all patients under-
oing BKA by the Vascular Surgery service of a tertiary care
eaching hospital from Jan 1, 2006 to Dec 31, 2007 was
Fig1. Overall primary graft patency by sex. Time (days).erformed. Demographic and clinical data was collected
